title: Aripiprazole in psychosis associated with Parkinson's disease.
abstract: Aripiprazole is an agent for treating schizophrenia. The authors assume that aripiprazole as a dopamine receptor partial agonist may be useful in treating PD patients. Three cases are presented in this study. All patients were evaluated by the same clinician, a neuropsychiatrist well trained in the use of Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression (CGI). Aripiprazole was effective for reducing psychosis in each case.
authors.affiliation: Clinical Investigation Dept., National Institute of Neurology and Neurosurgery of México. Insurgentes sur 3877, Colonia la fama, Tlalpan, Mexico DF 14269. elmerlopez@hotmail.com
authors.forename: Elmer
authors.initials: E
authors.lastname: López-Meza
authors.forename: Angel
authors.initials: A
authors.lastname: Ruiz-Chow
authors.forename: Jesus
authors.initials: J
authors.lastname: Ramirez-Bermudez
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications*; D010879:Piperazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D015363:Quinolones / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole